1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow LY03010: new trials by email Literature Review of LY03010 trials Research Report on LY03010
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients LY03010, Invega Sustenna 156 MG in 1 ML Prefilled Syringe - Schizo Affective Disorder, Schizophrenia | Phase 1 | Completed | Luye Pharma Group Ltd. | 48 | 2018-12-12 | 2019-08-13 |
Psychotic Disorders (1) · Schizophrenia (1)
United States (1)
Amy Sun, MD PhD (1)